German insurers win discounts on Gilead's Sovaldi
January 24, 2015 at 11:58 AM EST
FRANKFURT, Jan 24 (Reuters) - U.S. biotechnology company Gilead has conceded its first discounts in Germany on its key hepatitis C drugs Sovaldi and Harvoni, German business weekly WirtschaftsWoche reported.